George, a quick note on <<While I made a point about Dr. Giroir his contribution was not discovering BPI but suggesting and convicing the co to use it for Meningococcemia. This is far different than what you have ust stated.>>
I think this is pretty close to what I stated, (which was Xoma dabbled for a while until stumbling on BPI, as I mentioned before as per a conversation with a former Xoma scientist, after being pushed by a Texas doc (Giroir [sp?]) to pursue it. ) except I used the word "push" instead of "suggest/convince." I meant the "push" to refer to the "pursue it," and that may not have been 100% clear. I never said Giroir discovered BPI, I assume Xoma has made an original contribution to that aspect at least as far as the cloning is concerned (have not reviewed the patents). I agree that one can choose to view the Giroir "episode" as positive if one so wishes.
I think the anti-CD20 project "competed" with anti-sepsis and immunotoxin projects, as BPI came later. Obviously, "pennies" is a figure of speach, and at least management did listen to the scientists who wanted to patent the stuff; I am told, and of course this is in the realm of rumor, that the scientists had to push hard to get (the old?) management even to do that (i.e. file the patent).
I still don't get that warm fuzzy feeling from this management, but do not take this personally. Like chirodoc I have long position on Xoma, and I doubt anything posted here makes a bit of a difference in the stock price.
PB |
